Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 20 (2), 453-7

Conversion of 4-cyanomethyl-pyrazole-3-carboxamides Into CB1 Antagonists With Lowered Propensity to Pass the Blood-Brain-Barrier

Affiliations

Conversion of 4-cyanomethyl-pyrazole-3-carboxamides Into CB1 Antagonists With Lowered Propensity to Pass the Blood-Brain-Barrier

Jean-Marie Receveur et al. Bioorg Med Chem Lett.

Abstract

A series of amides, amidines and amidoximes have been made from the corresponding nitrile compounds, to provide potent antagonists and inverse agonists for the CB1 receptor with considerably lower lipophiliciy, higher polar surface area and improved plasma/brain ratios compared to the centrally acting rimonabant. Extensive investigations of ADME and in vivo pharmacological properties led to selection of the amide series and specifically the 4-(4-fluorophenyl)piperidin-4-ol derivative D4. A clear improvement in the peripheral profile over rimonabant was seen, although some contribution of central effect on the pronounced weight reduction in obese mice cannot be ruled out.

Similar articles

See all similar articles

Cited by 13 PubMed Central articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback